Hymecromone ( DrugBank: Hymecromone )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
94	原発性硬化性胆管炎	1

94. 原発性硬化性胆管炎

臨床試験数 : 148 / 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05295680 (ClinicalTrials.gov)	November 2022	4/3/2022	Oral Hymecromone to Treat Adolescents and Adults With Primary Sclerosing Cholangitis.	A Study of Oral Hymecromoneto Treat Adolescents and Adults With Primary Sclerosing Cholangitis(HAAPS ...	Primary Sclerosing Cholangitis	Drug: Hymecromone	Paul Bollyky	NULL	Not yet recruiting	14 Years	75 Years	All	24	Phase 2	United States

First Previous1Next Last